QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block

Rolando Cimaz, Marco Stramba-Badiale, Antonio Brucato, Luca Catelli, Paola Panzeri, Pier Luigi Meroni

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Objective. To analyze the electrocardiograms (EKGs) of infants born to mothers with anti-SSA/Ro antibodies in order to evaluate the QT interval (the time from the beginning of the QRS complex to the end of the T wave). Methods. Sera from mothers and children were analyzed for anti-Ro and anti- SSB/La antibodies by enzyme-linked immunosorbent assay (ELISA) and by Western blot analysis. Fine specificity of anti-Ro antibodies was evaluated by solid- phase ELISA against recombinant 52- and 60-kd proteins and by Western blot. A retrospective chart review was conducted for EKG analysis. Twenty-eight EKG tracings (21 from anti-Ro-positive and 7 from anti-Ro-negative infants born to mothers with autoimmune diseases) were analyzed by a single investigator who was blinded to the infant's antibody status. The QT interval was measured and corrected for heart rate according to Bazett's formula. Results. The mean QT interval was significantly longer in anti-Ro-positive than in anti-Ro- negative infants, also after correction for heart rate (QTc) (P = 0.001). Nine of 21 anti-Ro-positive infants and 0 of 7 anti-Ro-negative infants had QTc values above the upper normal limit (440 msec). A 24-hour EKG recording was performed on 5 patients and confirmed the QT prolongation. These infants were subsequently treated with a beta-blocker in order to prevent arrhythmias. Conclusion. Infants born to mothers who carry anti-Ro autoantibodies may show QT interval prolongation and should be monitored with EKG during the first months of life.

Original languageEnglish
Pages (from-to)1049-1053
Number of pages5
JournalArthritis and Rheumatism
Volume43
Issue number5
DOIs
Publication statusPublished - May 2000

Fingerprint

Electrocardiography
Mothers
Heart Rate
Western Blotting
Enzyme-Linked Immunosorbent Assay
Congenital heart block
Antibodies
Autoantibodies
Autoimmune Diseases
Cardiac Arrhythmias
Anti-Idiotypic Antibodies
Research Personnel
Serum
Proteins
SS-A antibodies

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. / Cimaz, Rolando; Stramba-Badiale, Marco; Brucato, Antonio; Catelli, Luca; Panzeri, Paola; Meroni, Pier Luigi.

In: Arthritis and Rheumatism, Vol. 43, No. 5, 05.2000, p. 1049-1053.

Research output: Contribution to journalArticle

Cimaz, Rolando ; Stramba-Badiale, Marco ; Brucato, Antonio ; Catelli, Luca ; Panzeri, Paola ; Meroni, Pier Luigi. / QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. In: Arthritis and Rheumatism. 2000 ; Vol. 43, No. 5. pp. 1049-1053.
@article{ce050a3691a141a197ecc2a3c630bcda,
title = "QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block",
abstract = "Objective. To analyze the electrocardiograms (EKGs) of infants born to mothers with anti-SSA/Ro antibodies in order to evaluate the QT interval (the time from the beginning of the QRS complex to the end of the T wave). Methods. Sera from mothers and children were analyzed for anti-Ro and anti- SSB/La antibodies by enzyme-linked immunosorbent assay (ELISA) and by Western blot analysis. Fine specificity of anti-Ro antibodies was evaluated by solid- phase ELISA against recombinant 52- and 60-kd proteins and by Western blot. A retrospective chart review was conducted for EKG analysis. Twenty-eight EKG tracings (21 from anti-Ro-positive and 7 from anti-Ro-negative infants born to mothers with autoimmune diseases) were analyzed by a single investigator who was blinded to the infant's antibody status. The QT interval was measured and corrected for heart rate according to Bazett's formula. Results. The mean QT interval was significantly longer in anti-Ro-positive than in anti-Ro- negative infants, also after correction for heart rate (QTc) (P = 0.001). Nine of 21 anti-Ro-positive infants and 0 of 7 anti-Ro-negative infants had QTc values above the upper normal limit (440 msec). A 24-hour EKG recording was performed on 5 patients and confirmed the QT prolongation. These infants were subsequently treated with a beta-blocker in order to prevent arrhythmias. Conclusion. Infants born to mothers who carry anti-Ro autoantibodies may show QT interval prolongation and should be monitored with EKG during the first months of life.",
author = "Rolando Cimaz and Marco Stramba-Badiale and Antonio Brucato and Luca Catelli and Paola Panzeri and Meroni, {Pier Luigi}",
year = "2000",
month = "5",
doi = "10.1002/1529-0131(200005)43:5<1049::AID-ANR13>3.0.CO;2-X",
language = "English",
volume = "43",
pages = "1049--1053",
journal = "Arthritis care and research : the official journal of the Arthritis Health Professions Association",
issn = "0893-7524",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block

AU - Cimaz, Rolando

AU - Stramba-Badiale, Marco

AU - Brucato, Antonio

AU - Catelli, Luca

AU - Panzeri, Paola

AU - Meroni, Pier Luigi

PY - 2000/5

Y1 - 2000/5

N2 - Objective. To analyze the electrocardiograms (EKGs) of infants born to mothers with anti-SSA/Ro antibodies in order to evaluate the QT interval (the time from the beginning of the QRS complex to the end of the T wave). Methods. Sera from mothers and children were analyzed for anti-Ro and anti- SSB/La antibodies by enzyme-linked immunosorbent assay (ELISA) and by Western blot analysis. Fine specificity of anti-Ro antibodies was evaluated by solid- phase ELISA against recombinant 52- and 60-kd proteins and by Western blot. A retrospective chart review was conducted for EKG analysis. Twenty-eight EKG tracings (21 from anti-Ro-positive and 7 from anti-Ro-negative infants born to mothers with autoimmune diseases) were analyzed by a single investigator who was blinded to the infant's antibody status. The QT interval was measured and corrected for heart rate according to Bazett's formula. Results. The mean QT interval was significantly longer in anti-Ro-positive than in anti-Ro- negative infants, also after correction for heart rate (QTc) (P = 0.001). Nine of 21 anti-Ro-positive infants and 0 of 7 anti-Ro-negative infants had QTc values above the upper normal limit (440 msec). A 24-hour EKG recording was performed on 5 patients and confirmed the QT prolongation. These infants were subsequently treated with a beta-blocker in order to prevent arrhythmias. Conclusion. Infants born to mothers who carry anti-Ro autoantibodies may show QT interval prolongation and should be monitored with EKG during the first months of life.

AB - Objective. To analyze the electrocardiograms (EKGs) of infants born to mothers with anti-SSA/Ro antibodies in order to evaluate the QT interval (the time from the beginning of the QRS complex to the end of the T wave). Methods. Sera from mothers and children were analyzed for anti-Ro and anti- SSB/La antibodies by enzyme-linked immunosorbent assay (ELISA) and by Western blot analysis. Fine specificity of anti-Ro antibodies was evaluated by solid- phase ELISA against recombinant 52- and 60-kd proteins and by Western blot. A retrospective chart review was conducted for EKG analysis. Twenty-eight EKG tracings (21 from anti-Ro-positive and 7 from anti-Ro-negative infants born to mothers with autoimmune diseases) were analyzed by a single investigator who was blinded to the infant's antibody status. The QT interval was measured and corrected for heart rate according to Bazett's formula. Results. The mean QT interval was significantly longer in anti-Ro-positive than in anti-Ro- negative infants, also after correction for heart rate (QTc) (P = 0.001). Nine of 21 anti-Ro-positive infants and 0 of 7 anti-Ro-negative infants had QTc values above the upper normal limit (440 msec). A 24-hour EKG recording was performed on 5 patients and confirmed the QT prolongation. These infants were subsequently treated with a beta-blocker in order to prevent arrhythmias. Conclusion. Infants born to mothers who carry anti-Ro autoantibodies may show QT interval prolongation and should be monitored with EKG during the first months of life.

UR - http://www.scopus.com/inward/record.url?scp=0034084203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034084203&partnerID=8YFLogxK

U2 - 10.1002/1529-0131(200005)43:5<1049::AID-ANR13>3.0.CO;2-X

DO - 10.1002/1529-0131(200005)43:5<1049::AID-ANR13>3.0.CO;2-X

M3 - Article

VL - 43

SP - 1049

EP - 1053

JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association

JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association

SN - 0893-7524

IS - 5

ER -